Frequency and sensitivity pattern of Extended Spectrum Beta Lactamase producing isolates in a tertiary care hospital laboratory of Pakistan

Journal of the Pakistan Medical Association

Volumn 55, Issue 10, 2005, Pages 436-439

  Jabeen, Kausar ^a   Zafar, Afia ^a   Hasan, Rumina ^a  

^a AGA KHAN UNIVERSITY HOSPITAL   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CARBAPENEM; CEFOTAXIME; CEFOTAXIME PLUS CLAVULANIC ACID; CLAVULANIC ACID; COTRIMOXAZOLE; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; OFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; UNCLASSIFIED DRUG;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CALCULATION; CHI SQUARE DISTRIBUTION; ENTEROBACTERIACEAE; ESCHERICHIA COLI; HOSPITAL INFECTION; HUMAN; KLEBSIELLA PNEUMONIAE; LOWEST INCOME GROUP; NONHUMAN; PAKISTAN; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TERTIARY HEALTH CARE;

ADOLESCENT; ADULT; BETA-LACTAMASES; CHILD; CHILD, PRESCHOOL; CROSS INFECTION; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; HOSPITALS, PUBLIC; HUMANS; INCIDENCE; MIDDLE AGED; PAKISTAN; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 31344468548     PISSN: 00309982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Nathisuwan S, Burgess S, Lewis JS 2nd. Extended-Spectrum β-Lactamases: Epidemiology, Detection, and Treatment. Pharmacotherapy 2001;21:920-8.
2. Jacoby GA, Mederios AA. More Extended Spectrum Beta Lactamases. Antimicrob Agents Chemother 1991;35:1697-704.
3. Jacoby GA. Genetics of extended-spectrum β-Lactamases. Eur J Clin Infect Dis 1994;13(suppl 1):2-11.
4. Winokur P, Jones RN, Pfaller MA (2000). Characterization of strains from Europe, North and Latin America, and Western Pacific that express an extended-spectrum β-lactamase phenotype: report from the SENTRY antimicrobial surveillance program (1997-1999). Presented at the 40th interscience conference on antimicrobial agents and chemotherapy. Toronto, Canada, September 17-20, 2000.
5. Adedeji A, Vangala K, Saurina G (2000). Molecular epidemiology of Klebsiella pneumoniae with extended-spectrum β-lactamase (ESBLs) in Brooklyn, NY. Presented at the 38th annual meeting of the Infectious Disease Society of America, New Orleans, LA, September 7-10, 2000.
6. Lautenbach E, Patel JB, Bilker WB, Edelstein PH, Fishman NO. Extended-spectrum β-lactamases-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact on resistance of outcomes. Clin Infect Dis 2001;32:1162-71.
7. Bell JM, Turnidge JD, Gales AC, Pfaller MA, Jones RN; the Sentry APAC Study Group. Prevalence of extended spectrum beta-lactamase (ESBL)-producing clinical isolates in the Asia-Pacific region and South Africa: regional results from SENTRY Antimicrobial Surveillance Program (1998-99). Diagn Microbiol Infect Dis 2002;42:193-8.
8. Mathur P, Kapil A, Das B, Dhawan B. Prevalence of extended spectrum beta lactamase producing gram negative bacteria in a tertiary care hospital. Ind J Med Res 2002;115:153-7.
9. Shah AA, Hasan F, Ahmed S, Hameed A. Extended spectrum beta lactamases in Enterobacteriaceae: related to age and gender. New Microbiol 2002;25:363-6.
10. Zaman G, Karamat AK, Abbasi AS, Rafi S, Ikram A. Prevalence of extended spectrum beta lactamase producing Enterobacteriaceae in nosocomial isolates. Pak Armed Forces Med J 1999;49:91-6.
11. Paterson DL, Yu LV. Extended spectrum beta lactamases: A call for improved detection and control Clin Inf Dis 1999;29:1419-22.
12. Karas JA, Pillay DG, Muckart D, Sterm AW. Treatment failure due to extended spectrum beta lactamases. J Antimicrob Chemother 1996;37:203-4.
13. Paterson DL, Ko W, Von Gottberg, Mohapatra S, Casellas J, Molazimglu L. In vitro susceptibility and clinical outcomes of bacterimia due to extended spectrum beta lactamase producing Klebsiella pneumoniae. Clin Inf Dis 1998;27:956.
14. Steward CD, Wallace D, Hubert SK, Lawton R, Fridkin SK, Gaynes RP. Ability of laboratories to detect emerging antimicrobial resistance in nosocomial pathogens: a survey of Project ICARE laboratories. Diagn Microbiol Infect Dis 2000;38:59-67.
15. Livermore DM, Yuan M. Antibiotic resistance and production of extended spectrum beta lactamases amongst Klebsiella spp. from ICUs in Europe. J Antmicrob Chemother 1996;38:409-24.
16. Tenover FC, Mohammed MJ, Gorton TS, Dembek ZF. Detection and reporting of organisms producing extended-spectrum β-Lactamase: survey of laboratories in Connecticut. J Clin Microbiol 1999;37:4065-70.
17. National Committee for Clinical Laboratory Standards (1999). Performance standards for Antimicrobial susceptibility testing. 9th informational supplement ed. Wayne PA: National Committee for Clinical Laboratory Standards.
18. Livermore DM, Brown DF. Detection of beta lactamase mediated resistance. J Antimicrob Chemother 2001;48 suppl:S1 59-64.
19. Emery CL, Weymouth LA. Detection and clinical significance of extended spectrum beta lactamases in a tertiary care medical center. J Clin Microbiol 1997;35:2061-7.
20. Koneman EW, Allen SD, Janda WM, Schereckenberger PC, Winn JWC. Color Atlas and Text Book of Diagnostic Microbiology, 5th ed. Lippincott, Philadelphia- New York 1997.
21. Morgan MA, Brock N, Schneider S. β-Lactam resistance in Escherichia coli and Klebsiella pneumoniae: laboratory detection and patient characteristics [abstr]. In: Program and abstracts of the 38th interscience conference on antimicrobial agents and chemotherapy. Washington, DC: American Society for Microbiology 1998, p. 143.
22. Inkhorn AE, Neugauser MM, Bearden DT, Quinn JP, Pendland SL. Extended spectrum beta lactamases: Frequency, risk factors and outcomes. Pharmacotherapy 2002;22:14-20.
23. Diekema DJ, Sader HS, Kugler K, Pfaller MA, Jones RN, Doern GV, et al. Survey of bloodstream infections due to gram-negative bacilli: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, and Latin America for the SENTRY antimicrobial surveillance program. Clin Infect Dis 1999;29:595-607.
24. Jacoby GA. Properties of plasmids responsible for production of extended spectrum beta lactamases. Eur J Clin Infect Dis 1994;13:S1:2-11.
25. Ho PL, Tsang DN, Que TL, Ho M, Yuen KY. Antimicrobial susceptibility and extended-spectrum beta-lactamases of Hong Kong isolates of enterobacteriaceae. APMIS 2000;108:237-40.